You are here

Home

Clinical Trials: Lung Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, October 26, 2020 - 12:00
A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS
Condition:   Acute Respiratory Distress Syndrome
Interventions:   Biological: low dose hMSC-Exos;   Biological: medium dose hMSC-Exos;   Biological: high dose hMSC-Exos;   Biological: Dosage 1of hMSC-Exos;   Biological: Dosage 2 of hMSC-Exos;   Biological: No hMSC-derived exosomes
Sponsors:   Ruijin Hospital;   Cellular Biomedicine Group Ltd.
Not yet recruiting
Posted: Friday, October 9, 2020 - 12:00
An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.
Condition:   Respiratory Distress Syndrome, Adult
Intervention:   Drug: agenT-797
Sponsor:   AgenTus Therapeutics, Inc.
Recruiting
Posted: Wednesday, October 7, 2020 - 12:00
Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia (WHO)
Condition:   Corona Virus Infection
Intervention:   Biological: T memory cells and NK cells
Sponsors:   Instituto de Investigación Hospital Universitario La Paz;   Universidad Autonoma de Madrid;   Universidad Miguel Hernandez de Elche;   Asociación Instituto de Investigación Sanitaria BioCruces;   Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Recruiting
Posted: Thursday, September 3, 2020 - 12:00
The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19
Conditions:   Covid19;   Acute Respiratory Distress Syndrome
Intervention:   Biological: CYP-001
Sponsors:   Cynata Therapeutics Limited;   Cerebral Palsy Alliance Research Institute
Recruiting
Posted: Wednesday, August 26, 2020 - 12:00
Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia
Condition:   Covid19
Intervention:   Drug: AstroStem-V
Sponsor:   Nature Cell Co. Ltd.
Not yet recruiting
Posted: Tuesday, August 25, 2020 - 12:00
MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome
Conditions:   Covid19;   ARDS, Human
Intervention:   Other: Mesenchymal stromal cell-based therapy
Sponsor:   D'Or Institute for Research and Education
Recruiting
Posted: Monday, August 24, 2020 - 12:00
Study of Descartes-30 in Acute Respiratory Distress Syndrome
Conditions:   Acute Respiratory Distress Syndrome;   Covid19
Intervention:   Biological: Descartes 30
Sponsor:   Cartesian Therapeutics
Not yet recruiting
Posted: Friday, August 21, 2020 - 12:00
An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection
Condition:   Severe Acute Respiratory Syndrome Coronavirus 2
Intervention:   Biological: Mesenchymal stem cell
Sponsor:   Rohto Pharmaceutical Co., Ltd.
Not yet recruiting
Posted: Wednesday, July 22, 2020 - 12:00
RAPA-501-Allo Off-the-Shelf Therapy of COVID-19
Condition:   Severe COVID-19 Disease
Interventions:   Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19;   Other: Placebo
Sponsors:   Rapa Therapeutics LLC;   Hackensack Meridian Health
Not yet recruiting
Posted: Wednesday, July 8, 2020 - 12:00
Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs
Condition:   COVID-19 Pneumonia
Interventions:   Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells;   Drug: Antibiotics;   Drug: Hormones;   Drug: Anticoagulant Therapy;   Device: Оxygen therapy
Sponsors:   Institute of Cell Therapy;   Kyiv City Clinical Hospital # 4
Recruiting

Pages